Cyprotex, the pharmaceuticals company specialising in the adverse effects of chemicals on living organisms, has signed a collaborative research agreement with US pharmaceuticals giant Pfizer.
The two parties will evaluate, further develop, and improve several of Cyprotex's proprietary offerings in the area of predictive toxicology.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
State pension gender gap ‘almost closed’ for new retirees – but private gap widensThe state pension amounts for men and women are on course “to be equal very shortly”, says Department for Work and Pensions
-
State pension boost could help millions – how to plug gaps in your National Insurance recordMore than 2 million people are not receiving the full amount of state pension and potentially could increase how much they get
